In this webinar, you will explore the latest developments of proton ConformalFLASH therapy, and discover how ConformalFLASH is poised to revolutionize radiotherapy by leveraging the unique physical advantages of the proton Bragg peak and biological sparing effects of Flash.

Listen to this webinar to gain valuable insights from clinical and industry experts, including Dr. Michele Kim from the University of Pennsylvania, along with Yohan Godart and Jarrick Nys, research experts at IBA. They share their expertise on the progress of ultra-high dose rate proton therapy and discuss the groundbreaking achievement of the first full end-to-end treatment of a canine patient with ConformalFLASH on Proteus® technology, matching clinical tolerances, from treatment planning to quality assurance.

Program:

• (01:23) Introduction to IBA ConformalFLASH: Overview of the significance of ConformalFLASH and its potential to revolutionize radiotherapy
• (06:38) ConformalFLASH on ProteusPLUS: Unique features of ConformalFLASH on ProteusPLUS, highlighting workflow enhancements and providing updates on the first full end-to-end treatment of a canine patient with ConformalFLASH on Proteus® technology
• (21:21) ConformalFLASH on ProteusONE: Developments made to bring ConformalFLASH on the ProteusONE
• (33:09) Take home messages
• (34:06) Q&A sessions